Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Mallia

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
The Journal of Allergy and Clinical Immunology|October 17, 2020
Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferonLydia J Finney, Nicholas Glanville, Hugo Farne, et al.
Thorax|October 30, 2021
Effect of CRTH2 antagonism on the response to experimental rhinovirus infection in asthma: a pilot randomised controlled trialHugo Farne, Nicholas Glanville, Nicholas Johnson, et al.
The Journal of Allergy and Clinical Immunology|April 27, 2018
Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbationsJie Zhu, Simon D Message, Patrick Mallia, et al.
Nature Communications|July 9, 2024
Neutrophil extracellular traps promote immunopathogenesis of virus-induced COPD exacerbationsOrestis Katsoulis, Marie Toussaint, Millie M Jackson, et al.
The Journal of Allergy and Clinical Immunology|April 14, 2020
Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPDJie Zhu, Patrick Mallia, Joseph Footitt, et al.
Allergy|December 4, 2021
T regulatory cells from atopic asthmatic individuals show a Th2-like phenotypeKirstin Jansen, Pattraporn Satitsuksanoa, Oliver F Wirz, et al.
American Journal of Respiratory and Critical Care Medicine|September 4, 2014
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosisPhillip L Molyneaux, Michael J Cox, Saffron A G Willis-Owen, et al.
Plos One|January 12, 2016
The MIF Antagonist ISO-1 Attenuates Corticosteroid-Insensitive Inflammation and Airways Hyperresponsiveness in an Ozone-Induced Model of COPDKirsty E Russell, Kian Fan Chung, Colin J Clarke, et al.
JAMA Internal Medicine|September 23, 2016
Azithromycin for Acute Exacerbations of Asthma : The AZALEA Randomized Clinical TrialSebastian L Johnston, Matyas Szigeti, Mary Cross, et al.
American Journal of Respiratory and Critical Care Medicine|April 9, 2020
Targeted Retreatment of Incompletely Recovered Chronic Obstructive Pulmonary Disease Exacerbations with Ciprofloxacin. A Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase III Clinical TrialAndrew I Ritchie, Simon E Brill, Ben H Vlies, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
The Journal of Allergy and Clinical Immunology|October 17, 2020
Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferonLydia J Finney, Nicholas Glanville, Hugo Farne, et al.
Thorax|October 30, 2021
Effect of CRTH2 antagonism on the response to experimental rhinovirus infection in asthma: a pilot randomised controlled trialHugo Farne, Nicholas Glanville, Nicholas Johnson, et al.
The Journal of Allergy and Clinical Immunology|April 27, 2018
Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbationsJie Zhu, Simon D Message, Patrick Mallia, et al.
Nature Communications|July 9, 2024
Neutrophil extracellular traps promote immunopathogenesis of virus-induced COPD exacerbationsOrestis Katsoulis, Marie Toussaint, Millie M Jackson, et al.
The Journal of Allergy and Clinical Immunology|April 14, 2020
Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPDJie Zhu, Patrick Mallia, Joseph Footitt, et al.
Allergy|December 4, 2021
T regulatory cells from atopic asthmatic individuals show a Th2-like phenotypeKirstin Jansen, Pattraporn Satitsuksanoa, Oliver F Wirz, et al.
American Journal of Respiratory and Critical Care Medicine|September 4, 2014
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosisPhillip L Molyneaux, Michael J Cox, Saffron A G Willis-Owen, et al.
Plos One|January 12, 2016
The MIF Antagonist ISO-1 Attenuates Corticosteroid-Insensitive Inflammation and Airways Hyperresponsiveness in an Ozone-Induced Model of COPDKirsty E Russell, Kian Fan Chung, Colin J Clarke, et al.
JAMA Internal Medicine|September 23, 2016
Azithromycin for Acute Exacerbations of Asthma : The AZALEA Randomized Clinical TrialSebastian L Johnston, Matyas Szigeti, Mary Cross, et al.
American Journal of Respiratory and Critical Care Medicine|April 9, 2020
Targeted Retreatment of Incompletely Recovered Chronic Obstructive Pulmonary Disease Exacerbations with Ciprofloxacin. A Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase III Clinical TrialAndrew I Ritchie, Simon E Brill, Ben H Vlies, et al.
Pageof 9